A court sided with Medtronic (NYSE:MDT), overturning a 2023 verdict ordering the medtech giant to pay a significant amount in ...

Hyperfine (Nasdaq:HYPR) announced that it made the first commercial sales of its next-generation Swoop system powered by new ...

Exactech today announced it appointed Dr. Richard J. Friedman as chief medical officer, effective immediately.

Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...

CMS proposed to keep Barostim as part of the New Technology Ambulatory Payment Classification (APC) 1580. This comes with an ...

With the launch, Anumana became the first organization to utilize the marketplace. Philips now plans to make offer the ...

UroMems received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant ...

Xeltis today announced encouraging preliminary data for its Xabg coronary artery bypass conduit (CABG) device.

Monogram develops semi- and fully autonomous robotic technologies. Zimmer Biomet expects its offerings to add new, ...

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Saluda Medical today announced the full launch of its EVA next-generation sensing technology for its neuromodulation therapy.

Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018″ peripheral ...